Compound Library definition

Compound Library means the collection of compounds (including, without limitation, the Licensed Compound) which as of the Execution Date is specifically and/or generically covered by one or more claims in U.S. Patent No. 5,262,439, entitled "Soluble Monoesters of Probucol", or any corresponding foreign patents or patent applications. The Compound Library shall include such compounds in any form, including any salt, hydrate or crystalline structure thereof.
Compound Library means (a) the CRT/ICR Existing Compound Library or any other compound library generated by or on behalf of the Company and/or the ICR pursuant to the conduct of Programme, but (b) excluding any compounds comprised in any CRT/ICR Background Library, other than Duplicate Compounds which remain Programme Compounds pursuant to Clause 7.6(b).
Compound Library means the discovery library comprised of physical samples of compounds that is stored in the Xxxxx Haystack compound storage unit, including all Intellectual Property related thereto, but excluding (a) all Excluded Ag Assets, and any samples, manufacturing standards, impurity standards, regulatory samples and other materials related to such Excluded Ag Assets and (b) for clarity, all Intellectual Property with respect to any compounds for which the physical samples are contained in the Compound Library solely to the extent related to current or previously marketed products of Descartes or any of its Subsidiaries (other than Transferred Ag Active Ingredients and Transferred Ag Formulated Products) or the Retained Descartes Pipeline.

Examples of Compound Library in a sentence

  • The Roche Bioscience Screening Library is not part of the Research Compound Library, but may, in Roche Bioscience's sole discretion, be used in HTS against the Targets.

  • With respect to Product Patent Rights claiming compounds in the Pfizer Compound Library or Licensed Products, Pfizer shall have those rights and duties ascribed to Rigel in Section 6.1, except that Pfizer will bear all related expenses.

  • In addition, if a compound is selected as a Lead Compound from the SIGNAL Compound Library and DPM ceases to pursue diligently development and commercialization of such compound, all rights to such Lead Compound shall revert to SIGNAL.

  • The development milestone payment set forth in Section 3.2(a)(iii) for U.S. Regulatory Approval of a Licensed Product shall be payable for the first Licensed Product developed by Schering and thereafter shall again be payable for each successive Licensed Product successfully developed by Schering which contains as the active ingredient a different compound from the Compound Library.

  • Prior to the designation of a Potential Compound from a Signal Compound Library as a Chemical Lead Compound pursuant to Section 2.4(d), Tanabe shall not engage in any attempts to elucidate the chemical structure of such Potential Compound, make any chemical modification to such Potential Compound, or test such Potential Compound for use outside the Inflammation Pathways or the Osteoporosis Pathways, as applicable.

  • The penultimate sentence of Section 5.6 of the Agreement is hereby amended to read as follows: Derivatives made as part of a Collaboration Medicinal Chemistry Program from compounds originating from the Tularik Screening Library shall be considered part of the Research Compound Library.

  • To the extent that the alleged infringement is based upon the use of Licensed Compound, another compound from the Compound Library or the Licensor Know-How, Schering shall have no obligation to pay royalties to Licensor under Section 3.3 with respect to sales of Licensed Product in such country(ies) during the pendency of any such suit.

  • Each party agrees and acknowledges that use of the substances contained in the Taisho Compound Library or the Tularik Compound Library, as the case may be, is limited solely to those activities contemplated by the Research Program, unless otherwise provided for in this Agreement, and are for research use only and shall not be administered to humans in any manner or form, except in accordance with the terms of this Agreement, subject to appropriate governmental approval.

  • Derivatives made as a result of HTS as part of the Research Collaboration from compounds originating from the Tularik Screening Library shall be considered part of the Research Compound Library.

  • Tularik acknowledges and agrees that Taisho is and shall remain the sole owner (or licensee with right to sublicense) of the Taisho Patents, the Taisho Know-How and the materials and compounds in the Taisho Compound Library and that Tularik has no rights in or to any of them other than the license and rights specifically granted herein.


More Definitions of Compound Library

Compound Library means the discovery library comprised of physical samples of compounds that is stored in the Xxxxx Haystack compound storage unit, including all Intellectual Property related thereto, but excluding (a) all Excluded Ag Assets, and any samples, manufacturing standards, impurity standards, regulatory samples and other materials related to such Excluded Ag Assets and (b) for clarity, all Intellectual Property with respect to any compounds for which the physical samples are contained in the Compound Library solely to the extent related to current or previously marketed products of Descartes or any of its Subsidiaries (other than Transferred Ag Active Ingredients and Transferred Ag Formulated Products) or the Retained Descartes Pipeline. “Concerto” means Bayer CropScience AG. “Concerto Assignment and Assumption Agreement” means the Partial Assignment and Assumption Agreement in the form attached hereto as Exhibit A-4 to be entered into by Descartes and/or its Subsidiaries, as applicable, and Fermat and/or its Subsidiaries, as applicable, at the Closing. “Concerto Data” means, collectively, Concerto Formulated Product Data and the Concerto Technical Data.

Related to Compound Library

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Library means an organized collection of resources made accessible to the public for reference or borrowing supported with money derived from taxation.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Licensed Compound means [***].

  • Program Technology means Program Know-How and Program Patents.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Program Materials means the documents and information provided by the Program Administrator specifying the qualifying EEMs, technology requirements, costs and other Program requirements, which include, without limitation, program guidelines and requirements, application forms and approval letters.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Manufacturing Know-How means all information, techniques, inventions, discoveries, improvements, practices, methods, knowledge, skill, experience and other technology, whether or not patentable or copyrightable, and any copyrights based thereon, relating to or necessary or useful for the production, purification, packaging, storage and transportation of Collaboration Products, including without limitation specifications, acceptance criteria, manufacturing batch records, standard operating procedures, engineering plans, installation, operation and process qualification protocols for equipment, validation records, master files submitted to the FDA, process validation reports, environmental monitoring processes, test data including pharmacological, toxicological and clinical test data, cost data and employee training materials.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Formulation means the combination of various ingredients designed to render the product useful and effective for the purpose claimed, or the form of pesticide as purchased by users;

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Licensor Technology means the Licensor Patents, the Licensor Know-How, Licensor Materials, and Non-Patent Rights Controlled by Licensor or its Affiliates embodied in Licensor Know-How or Licensor Materials.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.